Jeroen Vangindertael
Investment Manager @ Ackermans & van Haaren
Brussels, Belgium
Jeroen Vangindertael is a Series B investor at Ackermans & van Haaren in Brussels focused on Medical and Health Care. Jeroen Vangindertael is the Investment Manager at Ackermans & van Haaren.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Jeroen Vangindertael invests in
Stages Jeroen Vangindertael invests in
Countries Jeroen Vangindertael invests in
Investment Focus
Industry
- Medical 2 (100%)
- Health Care 2 (100%)
- Therapeutics 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Country
- Belgium 1 (50%)
- The Netherlands 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Confo Therapeutics
|
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO body-stabilized active state conformations ofthese receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention. | $65.2M / Series B / Jul 26, 2024 | |
Vico Therapeutics
|
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands. | $72.1M / Series B / Jan 05, 2024 |
Co-Investors
Kurma Partners
3 deals together
EQT Life Sciences
2 deals together
BioGeneration Ventures
1 deal together
Capricorn Partners
1 deal together
Driehaus Capital Management
1 deal together
Droia Ventures
1 deal together
About Ackermans & van Haaren
Ackermans & van Haaren is a diversified group active in 5 segments: Marine Engineering & Infrastructure; Private Banking; Real Estate, Leisure & Senior Care; Energy & Resources; Development Capital. Marine Engineering & Infrastructure: DEME, one of the largest dredging companies in the world - Algemene Aannemingen Van Laere,a leading contractor in Belgium. Ackermans & van Haaren is an independent and diversified group aiming at creating shareholder value through long-term investments in a limited number of companies with growth potential on an international level.
Ackermans & van Haaren Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jeroen Vangindertael
Investment Manager
|
|||
Luc Bertrand
CEO
|
|||
Matthias De Raeymaeker
Investment manager
|
|||
Philip Heylen
Business Development Manager
|
|||
|
Pierre Macharis
Non Executive Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jeroen Vangindertael invest in?
Jeroen Vangindertael invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jeroen Vangindertael last invest?
The most recent investment recorded for Jeroen Vangindertael closed in Jul 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
